Prospective Study in Pregnant Women With Hypercoagulopathy

Prospective Study of Hypercoagulation in Pregnant Women

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00215969

Enrollment

600

Registered

2005-09-22

Start date

2004-01-31

Completion date

2007-10-31

Last updated

2006-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eclampsia, Pre-Eclampsia

Keywords

Pre-eclampsia, Pregnancy, Hypercoagulation, Screening, Cardiovascular complications

Brief summary

Pre-eclampsia is one of the most common causes of maternal and fetal morbidity and mortality. The aim of this study is to identify pregnant women at risk for pre-eclampsia or other cardiovascular complications at a very early state of the disease, and thereby improve the current method of screening.

Detailed description

600 pregnant women will be included in the project and followed in a standardized manner during their pregnancy. On a regular basis blood- and urine samples will be taken throughout their pregnancy and until 1 month after delivery and analyzed for a large variety of coagulation factors in order to identify factors that might predict an increased risk of developing pre-eclampsia and/or cardiovascular events. In addition a DNA-sample is taken if consented in order to evaluate genetic factors.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Pregnant women attending the midwife at Hilleroed Hospital, Frederiksborg County, Denmark.

Exclusion criteria

* Mental disease. * Problems understanding or reading Danish.

Countries

Denmark

Contacts

Primary ContactAnita S Andersen, MD

asan@fa.dk+45 4829 6828

Outcome results